Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral oxycodone versus intravenous fentanyl for analgesia during colonoscopy
IRCT20111010007752N13Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Oct 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of oxycodone, fentanyl and propofol in acute pain (2 arms), sponsored by Babol University of Medical Sciences. Primary endpoint: Pain intensity. Started Oct 2022; status: completed.
02
Drugs
oxycodonefentanylpropofol
03
Conditions
acute pain
Beyond the preview
Go deeper on IRCT20111010007752N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20111010007752N13.